India registered its first COVID-19 case on 30-January-2020 in Kerala. The cases since then are on a continuous rise. The Government of India in order to contain the spread of novel coronavirus
-Therapeutic-Pipeline,-Va.jpg)
COVID-19 Novel Coronavirus 19 Therapeutic Pipeline Vaccines Diagnostics Competitive Landscape 2020
DelveInsight’s ‘COVID-19 Novel Coronavirus 19 Therapeutic Pipeline Vaccines Diagnostics Competitive Landscape 2020’ report proffers a solid foundation to start – or progress – further into the research and development of therapies for COVID-19 pandemic, by providing understanding of the causes and symptoms, provide analysis on the morbidity and mortality due to transmission, as well as create a detailed profile of the present stand of the treatment and prevention measures taking place to tackle COVID-19 in the healthcare vertical. It covers a detailed description of the virus associated risks, new diagnostics approaches, novel treatment approaches and vaccines. The report also provides competitive assessment of the key companies involved in the clinical research for new therapies, along with a comprehensive coverage of present Market Trends and Unmet Needs of the healthcare market in the current pandemic situation.
---Pipeline-Insight,-2020.jpg)
COVID-19 (CoronaVirus) – Pipeline Insight, 2020
DelveInsight’s ‘COVID-19 (CoronaVirus) – Pipeline Insight, 2020’ report covers a detailed overview of the disease, its etiology, and clinical symptoms. The report aims to provide all the therapeutic developments in the market to combat COVID 19, covers the current and emerging therapeutic approaches, as well as the impact of upcoming therapies on disease landscape and technological advancements. Additionally, the report provides extensive coverage of the pipeline products, their clinical phase of trials, mechanism of action, details on whether they are repurposed or novel, their route of administration, and the key company manufacturing and developing the product.
